After more than a decade of litigation, where Proneuron accused Teva of endangering the lives of patients and Teva accused Proneuron’s founder of distorting the clinical trial results, the District Court’s ruling was ratified: Teva conducted a clinical trial that was not properly planned and it must return the rights to Copaxone for non-Multiple Sclerosis indications.
Proneuron was represented by attorneys, Gabriel Moyal Maor, Menachem Abramovich, Yaron Sobol and Eleanor Stark.
To read the full article in Hebrew click here.
+97237770140 
